AI assistant
Sending…
RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2018
Feb 16, 2018
30849_dirs_2018-02-16_a9939999-db6a-4bc3-ad4e-14ebc9702bbb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2018-02-14
Reporting Person: Smith Hunter C (CFO and Treasurer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-14 | Employee Stock Option (Right to Buy) | $25.79 | A | 61000 | Acquired | 2028-02-13 | Common Stock (61000) | Direct |
Footnotes
F1: This option was granted on February 14, 2018 and the shares underlying this option vest in sixteen equal quarterly installments.
More from RHYTHM PHARMACEUTICALS, INC.
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 3